UFC Fight Pass will have its biggest headliner ever on Feb. 27.
UFC President Dana White announced on Thursday that Anderson Silva will face Michael Bisping when the Las Vegas-based promotion travels to the O2 Arena in London for a Fight Night event. The card will air in its entirety on Fight Pass, the UFC’s digital streaming platform. Bisping was originally scheduled to face Gegard Mousasi in a featured middleweight bout; the UFC is currently searching for a new opponent for Mousasi.
Silva tested positive for two different anabolic steroids – drostanolone metabolites and androstane -- during a UFC 183 pre-fight drug test. “The Spider” also tested positive for oxazepam, which is used to relieve anxiety, and temazepam, an anti-insomnia medication, in a post-fight urine test administered on Jan. 31. In addition, the former middleweight champ again tested positive for drostanolone metabolites.
The Brazilian blamed his failed steroid test on a tainted sexual enhancement drug but was suspended for one year and fined $380,000 by the Nevada Athletic Commission. His five-round verdict over Nick Diaz was overturned to a no contest. Silva’s suspension will officially end on Jan. 31. The 40-year-old fighter’s last victory came at UFC 153, when he stopped Stephan Bonnar inside of a round.
Bisping, 36, has won three of his last four Octagon appearances. The Englishman last appeared at UFC Fight Night in Scotland on July 18, when he captured a five-round split verdict over Thales Leites. In his other 2015 bout, “The Count” outpointed C.B. Dollaway at UFC 186.